The Progression and Integration of the Statistical Canda at Merck

Abstract

Merck has submitted its second generation statistical computer assisted new drug application (CANDA) to the Food and Drug Administration (FDA). Continued development at Merck of the CANDA focused on the implementation of advanced features, analysis and implementation of a new hardware platform, and the initial incorporation of the CANDA as an internal new drug application (NDA) development tool.